J Pediatr Infect Dis 2022; 17(02): 112-118
DOI: 10.1055/s-0042-1743577
Original Article

The Effects of COVID-19 on Oxidative Stress and Antioxidant Defense Mechanism in Children

1   Division of Pediatric Emergency, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey
,
Mustafa O. Kaynak
1   Division of Pediatric Emergency, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey
,
Suna Sabuncuoglu
2   Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey
,
Gozde Girgin
2   Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey
,
Pembe D. Oygar
3   Division of Pediatric Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey
,
Yasemin Ozsurekci
3   Division of Pediatric Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey
,
Ozlem Teksam
1   Division of Pediatric Emergency, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey
› Author Affiliations
Funding None.

Abstract

Objective Oxidative stress and antioxidants play an important role in infections' response. We aimed to investigate the potential association between oxidative stress and the pathogenesis of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection.

Methods We analyzed oxidant and antioxidant parameters from serum samples of children with novel corona virus disease 2019 (COVID-19) besides demographic and clinical data of children. Serum levels of the 8-hydroxy deoxyguanosine (8-OHdG), protein carbonyl (CO), malondialdehyde (MDA), total glutathione (GSH), superoxide dismutase (SOD), catalase (CT), and glutathione peroxidase (GPx) enzyme activities were evaluated and compared between groups.

Results A total of 96 children were evaluated, including 32 patients with confirmed COVID-19 (group 1), 35 patients with symptomatic infections without COVID-19 (group 2), and 29 healthy patients as a control group (group 3). Group 1 included 7 (21.8%) asymptomatic, 22 (68.7%) mild, and 3 (9.5%) moderate patients according to the severity of the disease. In all groups, there were no significant differences in oxidative stress and antioxidant parameter levels (p > 0.05). Furthermore, no statistical difference was found when the parameters of patients with COVID-19 and healthy children were evaluated according to disease course.

Conclusion Serum levels of oxidant and antioxidant parameters were similar in children infected with SARS-CoV-2 and other infectious agents. However, further studies, including children with severe to critical disease, are necessary to characterize the oxidative stress, antioxidants, cytokine responses in COVID-19, and elucidate the pathogenesis.

Ethical Approval and Consent to Participate

The written consents from the patient families were obtained according to the Declaration of Helsinki (1964) and the study was approved by the ethics committee of Hacettepe University (identifier no.: GO 20/431; approval date: May 2020).


Authors' Contributions

Manuscript preparation: O.A.; literature search: O.A., M.O.K., and O.T.; figure: O.A., Y.O., and O.T.; study design: O.A., S.S., Y.O., and O.T.; data collection: M.O.K., S.S., and G.G.; data analysis: O.A. and P.D.O.; data interpretation: O.A., Y.O., and O.T.; writing: O.A., S.S., Y.O., and O.T.. All authors read and approved the final manuscript.




Publication History

Received: 01 November 2021

Accepted: 27 January 2022

Article published online:
04 March 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Zhu N, Zhang D, Wang W. et al; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382 (08) 727-733
  • 2 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323 (13) 1239-1242
  • 3 Zimmermann P, Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child 2020:archdischild-2020-320338
  • 4 Karadag-Oncel E, Erel O, Ozsurekci Y. et al. Plasma oxidative stress and total thiol levels in Crimean-Congo hemorrhagic fever. Jpn J Infect Dis 2014; 67 (01) 22-26
  • 5 Liu M, Chen F, Liu T, Chen F, Liu S, Yang J. The role of oxidative stress in influenza virus infection. Microbes Infect 2017; 19 (12) 580-586
  • 6 Ciencewicki J, Trivedi S, Kleeberger SR. Oxidants and the pathogenesis of lung diseases. J Allergy Clin Immunol 2008; 122 (03) 456-468 , quiz 469–470
  • 7 Park HS, Kim SR, Lee YC. Impact of oxidative stress on lung diseases. Respirology 2009; 14 (01) 27-38
  • 8 Delgado-Roche L, Mesta F. Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection. Arch Med Res 2020; 51 (05) 384-387
  • 9 Derouiche S. Oxidative stress associated with SARS-Cov-2 (COVID-19) increases the severity of the lung disease-a systematic review. J Infect Dis Epidemiol 2020; 6: 121
  • 10 Hosakote YM, Jantzi PD, Esham DL. et al. Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2011; 183 (11) 1550-1560
  • 11 van den Brand JM, Haagmans BL, van Riel D, Osterhaus AD, Kuiken T. The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models. J Comp Pathol 2014; 151 (01) 83-112
  • 12 World Health Organization. Clinical management of COVID-19: interim guidance. 27 May 2020. Accessed June 12, 2020 at: https://apps.who.int/iris/bitstream/handle/10665/332196/WHO-2019-nCoV-clinical-2020.5-eng.pdf?sequence=1&isAllowed=y
  • 13 Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223): 497-506
  • 14 Cui X, Zhao Z, Zhang T. et al. A systematic review and meta-analysis of children with coronavirus disease 2019 (COVID-19). J Med Virol 2021; 93 (02) 1057-1069
  • 15 Brodin P. Why is COVID-19 so mild in children?. Acta paediatrica 2020; 109 (06) 1082-1083
  • 16 Zhu L, Lu X, Chen L. Possible causes for decreased susceptibility of children to coronavirus. Pediatr Res 2020; 88 (03) 342
  • 17 Hennet T, Peterhans E, Stocker R. Alterations in antioxidant defences in lung and liver of mice infected with influenza A virus. J Gen Virol 1992; 73 (Pt. 1): 39-46
  • 18 Komaravelli N, Casola A. Respiratory viral infections and subversion of cellular antioxidant defenses. J Pharmacogenomics Pharmacoproteomics 2014; 5 (04) 1000141
  • 19 Goyal P, Choi JJ, Pinheiro LC. et al. Clinical characteristics of COVID-19 in New York city. N Engl J Med 2020; 382 (24) 2372-2374
  • 20 Wong CK, Lam CW, Wu AK. et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 2004; 136 (01) 95-103
  • 21 Mahallawi WH, Khabour OF, Zhang Q, Makhdoum HM, Suliman BA. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine 2018; 104: 8-13
  • 22 Woo PC, Huang Y, Lau SK, Yuen KY. Coronavirus genomics and bioinformatics analysis. Viruses 2010; 2 (08) 1804-1820